Find Trials Near
Speak with a clinical trials expert
Have multiple conditions? Click here

You are viewing Clinical Trials in Oklahoma City, Oklahoma

Map View Full Map View Map

Refine your Search


  • Sort By:
  • Title
  • City
  • State
  • Zip

NEW Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older

Oklahoma City
Oklahoma
Age: 18 - Any
Conditions: Influenza

NEW Smoking Cessation in Women With Gynecological Conditions

Oklahoma City
Oklahoma
73104
Age: 18 - 65
Conditions: Hematology, Smoking Cessation, Women's Studies

NEW Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes

Oklahoma City
Oklahoma
73190
Age: Any - 25
Conditions: Hospital, Renal Impairment / Chronic Kidney Disease

NEW Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

Oklahoma City
Oklahoma
Age: 18 - Any
Conditions: Anemia, Renal Impairment / Chronic Kidney Disease

NEW Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis

Oklahoma City
Oklahoma
73112
Age: 18 - 80
Conditions: Arthritis, Rheumatoid Arthritis

NEW The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Oklahoma City
Oklahoma
73120
Age: 18 - Any
Conditions: Peripheral Vascular Disease

NEW The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Oklahoma City
Oklahoma
73120
Age: 18 - Any
Conditions: Peripheral Vascular Disease

NEW The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Oklahoma City
Oklahoma
73120
Age: 18 - Any
Conditions: Peripheral Vascular Disease

NEW Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Oklahoma City
Oklahoma
Age: 18 - 80
Conditions: Arthritis, Rheumatoid Arthritis

NEW Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Oklahoma City
Oklahoma
Age: 50 - 85
Conditions: Alzheimer Disease, Cognitive Studies

NEW Pediatric Open-Label Extension Study

Oklahoma City
Oklahoma
73116
Age: 6 - 17
Conditions: Autism, Depression, Neurology, Psychiatric, Schizophrenia

NEW S1304, Testing Two Doses of Carfilzomib With Dexamethasone for Relapsed or Refractory Myeloma

Oklahoma City
Oklahoma
73190
Age: 18 - Any
Conditions: Blood Cancer, Hematology

NEW Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

Oklahoma City
Oklahoma
73190
Age: Any - 29
Conditions: Blood Cancer, Hematology, Infectious Disease, Lymphoma

NEW Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis

Oklahoma City
Oklahoma
73190
Age: 18 - Any
Conditions: Dental

NEW Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus

Oklahoma City
Oklahoma
Age: 18 - Any
Conditions: Lupus

NEW Post-Operative Pain Management With NSAIDS

Oklahoma City
Oklahoma
73190
Age: 18 - Any
Conditions: Post-Surgical Pain

NEW Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids

Oklahoma City
Oklahoma
73104
Age: 18 - 64
Conditions: Gastrointestinal

NEW Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD

Oklahoma City
Oklahoma
73116
Age: 40 - Any
Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary

NEW Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD

Oklahoma City
Oklahoma
73116
Age: 40 - Any
Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary

NEW Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD

Oklahoma City
Oklahoma
73116
Age: 40 - Any
Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary

NEW Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD

Oklahoma City
Oklahoma
73116
Age: 40 - Any
Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary

NEW Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD

Oklahoma City
Oklahoma
73116
Age: 40 - Any
Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary

NEW Long Term Safety of Naldemedine

Oklahoma City
Oklahoma
Age: 18 - 80
Conditions: Constipation

NEW Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation

Oklahoma City
Oklahoma
Age: 18 - 80
Conditions: Constipation

NEW Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

Oklahoma City
Oklahoma
73104
Age: 18 - Any
Conditions: Cancer, Digestive Disease, Endocrine, Gastrointestinal

NEW Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)

Oklahoma City
Oklahoma
73120
Age: Any
Conditions: Breast Cancer

NEW Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)

Oklahoma City
Oklahoma
73104
Age: Any
Conditions: Breast Cancer

NEW Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF

Oklahoma City
Oklahoma
73104
Age: 18 - Any
Conditions: Cardiology

NEW A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian

Oklahoma City
Oklahoma
73104
Age: 21 - 90
Conditions: Cancer

NEW Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

Oklahoma City
Oklahoma
73120
Age: 18 - Any
Conditions: Cancer, Lung Cancer

NEW T and B Cell Responses in Autoimmune Diseases

Oklahoma City
Oklahoma
73104
Age: 8 - 60
Conditions: Arthritis, Crohns Disease, Diabetes, Gastrointestinal, Infectious Disease, Multiple Sclerosis, Neurology, Psoriasis, Rheumatoid Arthritis

NEW Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

Oklahoma City
Oklahoma
73104
Age: 18 - 65
Conditions: Lupus

NEW A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms

Oklahoma City
Oklahoma
73112
Age: 40 - 65
Conditions: Women's Studies

NEW Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients

Oklahoma City
Oklahoma
Age: 18 - 80
Conditions: High Cholesterol

NEW A Study of SI-6603 in Patients With Lumbar Disc Herniation

Oklahoma City
Oklahoma
Age: 30 - 70
Conditions: Orthopedic

NEW Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer

Oklahoma City
Oklahoma
73190
Age: 18 - Any
Conditions: Cervical Cancer

NEW Optimal Protein Supplementation for Critically Ill Patients

Oklahoma City
Oklahoma
73190
Age: 18 - Any
Conditions: Hospital

NEW Gel-One Treatment in Knee Osteoarthritis

Oklahoma City
Oklahoma
Age: 40 - 80
Conditions: Osteoarthritis (OA)

NEW Longitudinal Study of Patients With Opioid-Induced Constipation

Oklahoma City
Oklahoma
73109
Age: 18 - 85
Conditions: Constipation

NEW An Observational Study in Patients With Asthma Initiating Treatment With Xolair (Omalizumab)

Oklahoma City
Oklahoma
Age: 12 - Any
Conditions: Asthma

NEW OCAST Cessation Study

Oklahoma City
Oklahoma
73104
Age: 18 - 65
Conditions: Smoking Cessation, Tobacco Consumers

NEW Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

Oklahoma City
Oklahoma
73119
Age: 18 - 81
Conditions: Constipation

NEW Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients

Oklahoma City
Oklahoma
Age: 18 - 80
Conditions: Endocrine

NEW ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial

Oklahoma City
Oklahoma
Age: 18 - Any
Conditions:

NEW Pediatric Autism Study

Oklahoma City
Oklahoma
73116
Age: 6 - 17
Conditions: Autism, Neurology, Psychiatric

NEW Pediatric Schizophrenia Efficacy and Safety Study

Oklahoma City
Oklahoma
73116
Age: 13 - 17
Conditions: Schizophrenia

NEW Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis

Oklahoma City
Oklahoma
73104
Age: 18 - Any
Conditions: Arthritis, Psoriasis

NEW A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Oklahoma City
Oklahoma
73190
Age: Any
Conditions: High Blood Pressure (Hypertension), Pulmonary

NEW A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Oklahoma City
Oklahoma
73104
Age: Any
Conditions: High Blood Pressure (Hypertension), Pulmonary

NEW A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Oklahoma City
Oklahoma
73104
Age: Any
Conditions: High Blood Pressure (Hypertension), Pulmonary

NEW Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

Oklahoma City
Oklahoma
Age: 18 - Any
Conditions: Hematology, Hospital

NEW Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

Oklahoma City
Oklahoma
73190
Age: 18 - Any
Conditions: Breast Cancer, Cancer, Cervical Cancer, Endometrial Cancer, Women's Studies
View Clinical Trial Facilities in Oklahoma
Return to Search Results
Updating search results
One moment     loading
BROWSE CLINICAL TRIALS BY STATE
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
Copyright 2015 Clinical Trials GPS | All Rights Reserved



Forgot Password?